News
Public · Published
IFF Swings To Q3 Loss; Raises FY26 Guidance
International Flavors & Fragrances reported a third-quarter net loss of $55 million, compared with net income of $40 million a year earlier, mainly because of a $236 million loss on assets held for sale and higher selling and administrative expenses. Sales rose 4% to $1.94 billion, and IFF raised the lower end of its 2026 sales outlook.
Published:
Updated:
What happened
International Flavors & Fragrances reported a third-quarter net loss of $55 million, compared with net income of $40 million a year earlier, mainly because of a $236 million loss on assets held for sale and higher selling and administrative expenses. Sales rose 4% to $1.94 billion, and IFF raised the lower end of its 2026 sales outlook.
Confirmed
Global impact / market context
The reported loss highlights how costs tied to assets being sold can outweigh improved sales and adjusted earnings in a quarter. Raising the lower end of the annual sales outlook points to stronger expected revenue, which could support planning for production and spending, though the article gives no profit forecast.
Analyst inference
IFF’s sales increased across its three reported segments, while its headline result shifted from profit to loss because of the held-for-sale asset charge and higher administrative and selling expenses. Investors therefore have contrasting signals: rising revenue and adjusted earnings, but a reported loss and an ongoing planned divestiture.
Analyst inference
What to watch
- Check whether IFF’s next results show sales within its raised 2026 range of $7.5 billion to $7.6 billion, and whether reported earnings recover from the quarterly loss. Analyst inference
- Watch for the planned Food Ingredients divestiture to close by the end of the second quarter of 2027, as IFF says it remains on track. Confirmed
- Track whether the completed $500 million accelerated share repurchase, which buys back shares quickly, changes the share count or cash available for operations. Analyst inference
Evidence
- Original source link unavailable